Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3α, 7β-2-hydroxy-5β-bile acid, UDCA) was first found in the bile of a black bear.
Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis.
Scope of the Report:
Ursodeoxycholic Acid used to treat liver disease. Ursodeoxycholic Acid has positive effects on treatment of liver disease. The classification of Ursodeoxycholic Acid includes Synthetic Ursodeoxycholic Acid and Extraction Ursodeoxycholic Acid. The proportion of Synthetic Ursodeoxycholic Acid in 2017 is about 73.4%, and the proportion of Extraction Ursodeoxycholic Acid in 2017 is about 26.57%.
Ursodeoxycholic Acid is application in Pharmacy and Health Products. The most of Ursodeoxycholic Acid is used in Health Products, and the market share in 2017 is about 69.2%.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 47% in 2017. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of 26.6% in 2017.
In China, about major production is for export. Asia is the main consumption regions. Japan and South Korea are the major consumer countries.
In the Asian region due to the traditional reasons ursodeoxycholic acid is mainly used as healthcare industry.
Europe is the main supplier of Ursodeoxycholic Acid, with production revenue market share over 41%, while the sales market share is 26.4% in 2017. That is to say, there are a number of exports in Europe. Asia is also the main supplier of Ursodeoxycholic Acid, with production revenue market share over 42%, while the sales market share is 47% in 2017.
Market competition is intense. With the development of society and the changing of consumer demand, the Ursodeoxycholic Acid industry will be more and more popular in the future.
The worldwide market for Ursodeoxycholic Acid is expected to grow at a CAGR of roughly 11.9% over the next five years, will reach 1040 million US$ in 2024, from 530 million US$ in 2019, according to a new study.
This report focuses on the Ursodeoxycholic Acid in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
ICE
Mitsubishi Tanabe Pharma
Daewoong Chemical
PharmaZell GmbH
Zhangshanbelling
Dipharma Francis
Grindeks
Erregierre
Abil Chempharma
Biotavia Labs
Suzhou Tianlu
Arcelor Chemicals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Synthetic UDCA
Extraction UDCA
Market Segment by Applications, can be divided into
Pharmacy
Health Products
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ursodeoxycholic Acid product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Ursodeoxycholic Acid, with price, sales, revenue and global market share of Ursodeoxycholic Acid in 2017 and 2018.
Chapter 3, the Ursodeoxycholic Acid competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ursodeoxycholic Acid breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Ursodeoxycholic Acid market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Ursodeoxycholic Acid sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis.
Scope of the Report:
Ursodeoxycholic Acid used to treat liver disease. Ursodeoxycholic Acid has positive effects on treatment of liver disease. The classification of Ursodeoxycholic Acid includes Synthetic Ursodeoxycholic Acid and Extraction Ursodeoxycholic Acid. The proportion of Synthetic Ursodeoxycholic Acid in 2017 is about 73.4%, and the proportion of Extraction Ursodeoxycholic Acid in 2017 is about 26.57%.
Ursodeoxycholic Acid is application in Pharmacy and Health Products. The most of Ursodeoxycholic Acid is used in Health Products, and the market share in 2017 is about 69.2%.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 47% in 2017. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of 26.6% in 2017.
In China, about major production is for export. Asia is the main consumption regions. Japan and South Korea are the major consumer countries.
In the Asian region due to the traditional reasons ursodeoxycholic acid is mainly used as healthcare industry.
Europe is the main supplier of Ursodeoxycholic Acid, with production revenue market share over 41%, while the sales market share is 26.4% in 2017. That is to say, there are a number of exports in Europe. Asia is also the main supplier of Ursodeoxycholic Acid, with production revenue market share over 42%, while the sales market share is 47% in 2017.
Market competition is intense. With the development of society and the changing of consumer demand, the Ursodeoxycholic Acid industry will be more and more popular in the future.
The worldwide market for Ursodeoxycholic Acid is expected to grow at a CAGR of roughly 11.9% over the next five years, will reach 1040 million US$ in 2024, from 530 million US$ in 2019, according to a new study.
This report focuses on the Ursodeoxycholic Acid in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
ICE
Mitsubishi Tanabe Pharma
Daewoong Chemical
PharmaZell GmbH
Zhangshanbelling
Dipharma Francis
Grindeks
Erregierre
Abil Chempharma
Biotavia Labs
Suzhou Tianlu
Arcelor Chemicals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Synthetic UDCA
Extraction UDCA
Market Segment by Applications, can be divided into
Pharmacy
Health Products
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ursodeoxycholic Acid product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Ursodeoxycholic Acid, with price, sales, revenue and global market share of Ursodeoxycholic Acid in 2017 and 2018.
Chapter 3, the Ursodeoxycholic Acid competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ursodeoxycholic Acid breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Ursodeoxycholic Acid market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Ursodeoxycholic Acid sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
